Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 59.90
+0.30 (0.50%)
Sep 4, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.01 billion as of September 4, 2026. Its market cap has decreased by -61.11% in one year.
Market Cap
1.01B
Enterprise Value
971.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
59.90
ChartMarket Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 1.01B, a decrease of -25.53%. That is a compound annual growth rate of -6.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.01B | -47.07% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BICO Group AB | 1.57B |
| Paxman AB | 1.35B |
| C-Rad AB | 1.23B |
| Sedana Medical AB | 1.14B |
| Episurf Medical AB | 818.73M |
| Bactiguard Holding AB | 571.22M |
| Senzime AB | 518.81M |
| OssDsign AB | 409.32M |